Comparison of TUSP Versus TURP for Treatment of Benign Prostatic Hyperplasia in a Small Prostate Volume

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-01

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of transurethral split of the prostate versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia in a small prostate volume: A prospective controlled study

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Transurethral Ventral Wall of Urethra-preserving Enucleation of Prostate

NCT01073241

Benign Prostatic Hyperplasia

UNKNOWN NA

Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate

NCT03157726

Benign Prostatic Hyperplasia

UNKNOWN NA

Real-Time (TRUS) Guidance in Endoscopic Treatment of BPH

NCT06922968

BPH (Benign Prostatic Hyperplasia)

NOT_YET_RECRUITING NA

TRP Versus Photo Selective Vaporization for Obstructive Benign Prostatic Hyperplasia Management

NCT01043588

Benign Prostatic Hyperplasia

COMPLETED NA

Bipolar Resection vs Enucleation of Prostate

NCT06983444

Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection Benign Prostatic Hyperplasia With Outflow Obstruction Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Transurethral resection of the prostate (TURP) was considered as the golden standard to treat benign prostatic hyperplasia (BPH) for decades. However, TURP was associated with low efficiency to alleviate the lower urinary tract symptoms and a significantly higher risk of bladder neck contracture (BNC) for patients with small-volume BPH. We aimed to compare the therapeutic effect of transurethral split of the prostate (TUSP) with TURP for patients with small-volume BPH (\<30 ml).

In this study, some selected small-volume BPH patients were randomly divided into two groups (TUSP and TURP group). The patient's baseline characteristics and perioperative outcomes were recorded. The follow-up was made at 6 months, 1 year and 2 years after surgical treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benign Prostatic Hyperplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test Group

Patients received the transurethral split of the prostate(TUSP) treatment.

Group Type EXPERIMENTAL

TUSP

Intervention Type PROCEDURE

Patients received the transurethral split of the prostate(TUSP) treatment.

Control Group

Patients received the transurethral resection of the prostate(TURP) treatment.

Group Type ACTIVE_COMPARATOR

TURP

Intervention Type PROCEDURE

Patients received the transurethral resection of the prostate(TURP) treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TUSP

Patients received the transurethral split of the prostate(TUSP) treatment.

Intervention Type PROCEDURE

TURP

Patients received the transurethral resection of the prostate(TURP) treatment.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Benign prostatic hyperplasia patients with surgical indication
* Maximum flow rate \<12ml/s
* Prostate volume \<30ml
* The international prostate symptoms score\>21
* Medication of α-adrenergic blockers for at least 3 months